Atlas Arteria (ASX:ALX) - Prezzo delle azioni, notizie e analisi

ALX Panoramica delle azioni

Atlas Arteria Limited possiede, sviluppa e gestisce strade a pedaggio. Maggiori dettagli

ALX analisi fondamentale
Punteggio fiocco di neve
Valutazione	3/6
Crescita futura	4/6
Prestazioni passate	2/6
Salute finanziaria	3/6
Dividendi	4/6

Premi

Negoziato a 49.4% al di sotto della nostra stima del suo valore equo

Si prevede che gli utili cresceranno del 21.84% all'anno

Analisi del rischio

Il dividendo di 8.4% non è ben coperto dagli utili o dai flussi di cassa liberi

Atlas Arteria Limited Concorrenti

Transurban Group

ASX:TCL

AU$39.0b

Qube Holdings

ASX:QUB

AU$6.9b

Aurizon Holdings

ASX:AZJ

AU$6.1b

Dalrymple Bay Infrastructure

ASX:DBI

AU$1.7b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Atlas Arteria
Prezzi storici delle azioni
Prezzo attuale dell'azione	AU$4.76
Massimo di 52 settimane	AU$5.88
Minimo di 52 settimane	AU$4.63
Beta	0.76
1Variazione di 1 mese	-4.80%
Variazione a 3 mesi	-6.67%
Variazione di 1 anno	-17.36%
3Variazione a 3 anni	-30.61%
Variazione a 5 anni	-38.18%
Variazione dall'IPO	673.98%

Notizie e aggiornamenti recenti

Recent updates

Is Now An Opportune Moment To Examine Atlas Arteria Limited (ASX:ALX)?

Apr 07

What Does Atlas Arteria Limited's (ASX:ALX) Share Price Indicate?

Dec 22

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 43% Undervaluation?

Aug 10

Is Atlas Arteria (ASX:ALX) Using Too Much Debt?

May 31

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 48% Undervaluation?

Apr 14

Debra Goodin Is The Independent Chairman of the Board of Atlas Arteria Limited (ASX:ALX) And They Just Picked Up 54% More Shares

Mar 03

Here's Why Atlas Arteria (ASX:ALX) Can Afford Some Debt

Feb 27

Atlas Arteria (ASX:ALX) Has Compensated Shareholders With A Respectable 78% Return On Their Investment

Jan 31

Atlas Arteria Limited (ASX:ALX) Shares Could Be 44% Below Their Intrinsic Value Estimate

Dec 27

How Many Atlas Arteria Limited (ASX:ALX) Shares Do Institutions Own?

Dec 06

Is There Now An Opportunity In Atlas Arteria Limited (ASX:ALX)?

Nov 19

Atlas Arteria (ASX:ALX) Has Gifted Shareholders With A Fantastic 142% Total Return On Their Investment

Jul 30

Rendimenti per gli azionisti

	ALX	AU Infrastructure	AU Mercato
7D	-0.6%	0.6%	1.5%
1Y	-17.4%	-0.7%	17.2%

Ritorno vs Industria: ALX ha avuto una performance inferiore rispetto al Australian Infrastructure che ha registrato un rendimento -0.7 % nell'ultimo anno.

Rendimento vs Mercato: ALX ha avuto una performance inferiore al mercato Australian che ha registrato un rendimento 17.2 % nell'ultimo anno.

Volatilità dei prezzi

Is ALX's price volatile compared to industry and market?
ALX volatility
ALX Average Weekly Movement	3.1%
Infrastructure Industry Average Movement	2.6%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.3%
10% least volatile stocks in AU Market	3.4%

Prezzo delle azioni stabile: ALX non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 3% ) di ALX è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
2009	n/a	Hugh Wehby	www.atlasarteria.com

Atlas Arteria Limited possiede, sviluppa e gestisce strade a pedaggio. Detiene una partecipazione del 31,14% nell'APRR e nell'A79 e del 31,17% nell'ADELAC, situate in Francia; una partecipazione del 100% nel Warnow Tunnel, situato a Rostock, in Germania; una partecipazione del 66,67% nella Chicago Skyway, situata a Chicago, e una partecipazione del 100% nella Dulles Greenway, situata in Virginia, negli Stati Uniti. La società era precedentemente nota come Macquarie Atlas Roads Limited e ha cambiato nome in Atlas Arteria Limited nel maggio 2018.

Atlas Arteria Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Atlas Arteria con la sua capitalizzazione di mercato?
ALX statistiche fondamentali
Capitalizzazione di mercato	AU$6.91b
Guadagni(TTM)	AU$300.20m
Ricavi(TTM)	AU$140.10m

23.0x

Rapporto P/E

49.3x

Rapporto P/S

ALX è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
ALX Conto economico (TTM)
Ricavi	AU$140.10m
Costo del fatturato	AU$47.80m
Profitto lordo	AU$92.30m
Altre spese	-AU$207.90m
Guadagni	AU$300.20m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

Feb 26, 2025

Utile per azione (EPS)	0.21
Margine lordo	65.88%
Margine di profitto netto	214.28%
Rapporto debito/patrimonio netto	27.2%

Come si è comportato ALX nel lungo periodo?

Vedi performance storica e confronto

Dividendi

8.4%

Rendimento attuale del dividendo

194%

Rapporto di remunerazione

ALX Panoramica delle azioni

Premi

Analisi del rischio

Atlas Arteria Limited Concorrenti

ASX:TCL

AU$39.0b

ASX:QUB

AU$6.9b

ASX:AZJ

AU$6.1b

ASX:DBI

AU$1.7b

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

Consensus revenue estimates fall by 13%

First half 2024 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Recent updates

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

Consensus revenue estimates fall by 13%

First half 2024 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Atlas Arteria Limited Appoints Hugh Wehby as Managing Director

Atlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025

Final dividend of AU$0.20 announced

Atlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024

Atlas Arteria Limited, Annual General Meeting, May 15, 2024

Atlas Arteria Limited, Annual General Meeting, May 16, 2024

Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)

Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Consensus EPS estimates fall by 11%

First half 2023 earnings released: EPS: AU$0.12 (vs AU$0.13 in 1H 2022)

Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023

Atlas Arteria Limited to Report First Half, 2024 Results on Aug 29, 2024

Atlas Arteria Limited Appoints Ken Daley as Director

Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023

Consensus EPS estimates fall by 15%

Full year 2022 earnings released: EPS: AU$0.25 (vs AU$0.19 in FY 2021)

Insufficient new directors

Atlas Arteria Limited Announces Board Changes

Atlas Arteria Limited (ASX:ALX) completed the acquisition of 66.67% stake in Skyway Concession Company, LLC from CPP Investments and OMERS Infrastructure.

Now 20% undervalued after recent price drop

Atlas Arteria Limited, Annual General Meeting, Apr 27, 2023

Consensus revenue estimates increase by 10%

Atlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023

Price target decreased to AU$6.96

Investor sentiment deteriorated over the past week

Atlas Arteria Limited Provides Distribution Guidance for the Year 2023

Atlas Arteria Limited (ASX:ALX) entered into an agreement to acquire a 66.67% stake in Skyway Concession Company, LLC for $2 billion.

Consensus EPS estimates fall by 14%

First half 2022 earnings released: EPS: AU$0 (vs AU$0.074 in 1H 2021)

Atlas Arteria Limited Provides Dividend Guidance for the First Half of 2022

Price target increased to AU$7.40

Investor sentiment improved over the past week

Atlas Arteria Limited Announces Executive Changes

Is Now An Opportune Moment To Examine Atlas Arteria Limited (ASX:ALX)?

Independent Non-Executive Director recently bought AU$76k worth of stock

Full year 2021 earnings: EPS and revenues miss analyst expectations

What Does Atlas Arteria Limited's (ASX:ALX) Share Price Indicate?

Insider recently bought AU$67k worth of stock

First half 2021 earnings released: EPS AU$0.074 (vs AU$0.14 loss in 1H 2020)

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 43% Undervaluation?

Is Atlas Arteria (ASX:ALX) Using Too Much Debt?

Price target decreased to AU$6.21

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 48% Undervaluation?

Debra Goodin Is The Independent Chairman of the Board of Atlas Arteria Limited (ASX:ALX) And They Just Picked Up 54% More Shares

Independent Chairman of the Board recently bought AU$100k worth of stock

Here's Why Atlas Arteria (ASX:ALX) Can Afford Some Debt

Full year 2020 earnings released: AU$0.061 loss per share (vs AU$0.024 profit in FY 2019)

Atlas Arteria Limited Announces Board Changes

New 90-day low: AU$5.97

Atlas Arteria Limited to Report Fiscal Year 2020 Results on Feb 25, 2021